XML 93 R82.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Supplemental Consolidating Data - Cash Flows (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2024
Jun. 30, 2023
Cash flows from operating activities:            
Net income $ 215,406 $ 232,233 $ 173,830 $ 301,829 $ 447,639 $ 475,659
Adjustments to reconcile Net income to Net cash provided by operating activities:            
Depreciation and amortization         80,376 72,225
Amortization of deferred loan origination costs         36,466 44,393
Amortization of financing origination fees         6,793 6,508
Provision for long-term employee benefits         (26,143) (33,656)
Employee benefit plan contributions and payments         (2,593) (2,882)
Stock compensation expense         28,995 44,413
Net change in wholesale finance receivables related to sales         (388,030) (267,942)
Provision for credit losses         117,040 109,642
Deferred income taxes         146 (4,251)
Other, net         14,965 (31,160)
Changes in current assets and liabilities:            
Accounts receivable, net         (65,927) (79,531)
Finance receivables – accrued interest and other         2,759 3,189
Inventories, net         235,539 94,636
Accounts payable and accrued liabilities         64,166 (16,047)
Other current assets         25,451 (4,676)
Total adjustments         130,003 (65,139)
Net cash provided by operating activities         577,642 410,520
Cash flows from investing activities:            
Capital expenditures         (87,835) (86,526)
Origination of finance receivables         (2,095,952) (2,128,983)
Collections on finance receivables         1,786,964 1,869,463
Other investing activities         (206) 850
Net cash used by investing activities         (397,029) (345,196)
Cash flows from financing activities:            
Proceeds from issuance of medium-term notes         495,856 1,446,304
Repayments of medium-term notes         0 (1,056,680)
Proceeds from securitization debt         547,618 547,706
Repayments of securitization debt         (506,489) (645,377)
Borrowings of asset-backed commercial paper         351,429 33,547
Repayments of asset-backed commercial paper         (125,654) (129,961)
Net decrease in unsecured commercial paper         (379,743) (75,229)
Net increase in deposits         56,007 122,288
Dividends paid         (47,359) (48,193)
Repurchase of common stock         (209,675) (169,645)
Other financing activities         8 76
Net cash provided by financing activities         181,998 24,836
Effect of exchange rate changes on cash, cash equivalents and restricted cash         (10,821) (490)
Net increase in cash, cash equivalents and restricted cash         351,790 89,670
Cash, cash equivalents and restricted cash:            
Cash, cash equivalents and restricted cash, beginning of period   1,648,811   1,579,177 1,648,811 1,579,177
Net (decrease) increase in cash, cash equivalents and restricted cash         351,790 89,670
Cash, cash equivalents and restricted cash, end of period 2,000,601   1,668,847   2,000,601 1,668,847
Reportable Legal Entities | Non-Financial Services Entities            
Cash flows from operating activities:            
Net income 162,731   130,872   355,095 387,258
Adjustments to reconcile Net income to Net cash provided by operating activities:            
Depreciation and amortization         75,768 67,720
Amortization of deferred loan origination costs         0 0
Amortization of financing origination fees         360 354
Provision for long-term employee benefits         (26,143) (33,656)
Employee benefit plan contributions and payments         (2,593) (2,882)
Stock compensation expense         27,896 42,174
Net change in wholesale finance receivables related to sales         0 0
Provision for credit losses         0 0
Deferred income taxes         2,145 233
Other, net         13,339 (25,290)
Changes in current assets and liabilities:            
Accounts receivable, net         (233,698) (147,730)
Finance receivables – accrued interest and other         0 0
Inventories, net         235,539 94,636
Accounts payable and accrued liabilities         48,395 (30,340)
Other current assets         9,347 (12,329)
Total adjustments         150,355 (47,110)
Net cash provided by operating activities         505,450 340,148
Cash flows from investing activities:            
Capital expenditures         (87,050) (85,401)
Origination of finance receivables         0 0
Collections on finance receivables         0 0
Other investing activities         (1,206) (1,650)
Net cash used by investing activities         (88,256) (87,051)
Cash flows from financing activities:            
Proceeds from issuance of medium-term notes         0 0
Repayments of medium-term notes           0
Proceeds from securitization debt         0 0
Repayments of securitization debt         0 0
Borrowings of asset-backed commercial paper         0 0
Repayments of asset-backed commercial paper         0 0
Net decrease in unsecured commercial paper         0 0
Net increase in deposits         0 0
Dividends paid         (47,359) (48,193)
Repurchase of common stock         (209,675) (169,645)
Other financing activities         8 76
Net cash provided by financing activities         (257,026) (217,762)
Effect of exchange rate changes on cash, cash equivalents and restricted cash         (10,595) (729)
Net increase in cash, cash equivalents and restricted cash         149,573 34,606
Cash, cash equivalents and restricted cash:            
Cash, cash equivalents and restricted cash, beginning of period   1,127,400   1,021,798 1,127,400 1,021,798
Net (decrease) increase in cash, cash equivalents and restricted cash         149,573 34,606
Cash, cash equivalents and restricted cash, end of period 1,276,973   1,056,404   1,276,973 1,056,404
Reportable Legal Entities | Financial Services Entities            
Cash flows from operating activities:            
Net income 52,771   43,043   92,533 88,320
Adjustments to reconcile Net income to Net cash provided by operating activities:            
Depreciation and amortization         4,608 4,505
Amortization of deferred loan origination costs         36,466 44,393
Amortization of financing origination fees         6,433 6,154
Provision for long-term employee benefits         0 0
Employee benefit plan contributions and payments         0 0
Stock compensation expense         1,099 2,239
Net change in wholesale finance receivables related to sales         0 0
Provision for credit losses         117,040 109,642
Deferred income taxes         (1,445) (4,413)
Other, net         1,637 (5,788)
Changes in current assets and liabilities:            
Accounts receivable, net         0 0
Finance receivables – accrued interest and other         2,759 3,189
Inventories, net         0 0
Accounts payable and accrued liabilities         171,199 80,563
Other current assets         9,589 6,836
Total adjustments         349,385 247,320
Net cash provided by operating activities         441,918 335,640
Cash flows from investing activities:            
Capital expenditures         (785) (1,125)
Origination of finance receivables         (4,210,218) (4,076,675)
Collections on finance receivables         3,531,504 3,551,887
Other investing activities         0 0
Net cash used by investing activities         (679,499) (525,913)
Cash flows from financing activities:            
Proceeds from issuance of medium-term notes         495,856 1,446,304
Repayments of medium-term notes           (1,056,680)
Proceeds from securitization debt         547,618 547,706
Repayments of securitization debt         (506,489) (645,377)
Borrowings of asset-backed commercial paper         351,429 33,547
Repayments of asset-backed commercial paper         (125,654) (129,961)
Net decrease in unsecured commercial paper         (379,743) (75,229)
Net increase in deposits         56,007 122,288
Dividends paid         0 0
Repurchase of common stock         0 0
Other financing activities         1,000 2,500
Net cash provided by financing activities         440,024 245,098
Effect of exchange rate changes on cash, cash equivalents and restricted cash         (226) 239
Net increase in cash, cash equivalents and restricted cash         202,217 55,064
Cash, cash equivalents and restricted cash:            
Cash, cash equivalents and restricted cash, beginning of period   521,411   557,379 521,411 557,379
Net (decrease) increase in cash, cash equivalents and restricted cash         202,217 55,064
Cash, cash equivalents and restricted cash, end of period 723,628   612,443   723,628 612,443
Consolidating Adjustments            
Cash flows from operating activities:            
Net income (96)   (85)   11 81
Adjustments to reconcile Net income to Net cash provided by operating activities:            
Depreciation and amortization         0 0
Amortization of deferred loan origination costs         0 0
Amortization of financing origination fees         0 0
Provision for long-term employee benefits         0 0
Employee benefit plan contributions and payments         0 0
Stock compensation expense         0 0
Net change in wholesale finance receivables related to sales         (388,030) (267,942)
Provision for credit losses         0 0
Deferred income taxes         (554) (71)
Other, net         (11) (82)
Changes in current assets and liabilities:            
Accounts receivable, net         167,771 68,199
Finance receivables – accrued interest and other         0 0
Inventories, net         0 0
Accounts payable and accrued liabilities         (155,428) (66,270)
Other current assets         6,515 817
Total adjustments         (369,737) (265,349)
Net cash provided by operating activities         (369,726) (265,268)
Cash flows from investing activities:            
Capital expenditures         0 0
Origination of finance receivables         2,114,266 1,947,692
Collections on finance receivables         (1,744,540) (1,682,424)
Other investing activities         1,000 2,500
Net cash used by investing activities         370,726 267,768
Cash flows from financing activities:            
Proceeds from issuance of medium-term notes         0 0
Repayments of medium-term notes           0
Proceeds from securitization debt         0 0
Repayments of securitization debt         0 0
Borrowings of asset-backed commercial paper         0 0
Repayments of asset-backed commercial paper         0 0
Net decrease in unsecured commercial paper         0 0
Net increase in deposits         0 0
Dividends paid         0 0
Repurchase of common stock         0 0
Other financing activities         (1,000) (2,500)
Net cash provided by financing activities         (1,000) (2,500)
Effect of exchange rate changes on cash, cash equivalents and restricted cash         0 0
Net increase in cash, cash equivalents and restricted cash         0 0
Cash, cash equivalents and restricted cash:            
Cash, cash equivalents and restricted cash, beginning of period   $ 0   $ 0 0 0
Net (decrease) increase in cash, cash equivalents and restricted cash         0 0
Cash, cash equivalents and restricted cash, end of period $ 0   $ 0   $ 0 $ 0